The co-existence of NS5A and NS5B resistance-associated substitutions is associated with virologic failure in Hepatitis C Virus genotype 1 patients treated with sofosbuvir and ledipasvir
Table 1
The baseline characteristics of the patients who were treated with sofosbuvir/ledipasvir (n = 493).